Non-Obstructive Coronaries In Patients Presenting With The Non St-Elevation Acute Coronary Syndrome
Shakir Zada1, Khalid Iqbal Bhatti1, Muhammad Zeb1
1National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|February 26, 2024
Summary
Non-obstructive coronary arteries are common in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). This study found 14.4% of NSTE-ACS patients had non-obstructive coronary arteries, highlighting a need for further research.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Cardiovascular diseases are a leading cause of mortality globally.
- Acute coronary syndrome (ACS) is a common manifestation, with non-ST elevation ACS (NSTE-ACS) accounting for 70% of cases.
- NSTE-ACS often involves partial or intermittent coronary artery occlusion, necessitating investigation into non-obstructive causes.
Purpose of the Study:
- To determine the prevalence and characteristics of non-obstructive coronary arteries in patients with NSTE-ACS.
- To investigate the demographic and clinical factors associated with non-obstructive coronary arteries in this patient cohort.
- To contribute to understanding NSTE-ACS in a Pakistani population.
Main Methods:
- A descriptive cross-sectional study was conducted at a tertiary care cardiac center.
- Included were 174 patients aged 30-70 years admitted with NSTE-ACS.
- Coronary angiography was used to identify non-obstructive coronary arteries (absence of ≥50% stenosis).
Main Results:
- The study included 174 patients (56.9% male, mean age 59.43±11.24 years).
- Prevalent comorbidities included hypertension (43.7%), hyperlipidemia (31.6%), and chronic kidney disease (11.5%).
- Non-obstructive coronary arteries were identified in 25 patients (14.4%).
Conclusions:
- Non-obstructive coronary arteries are a significant finding in patients presenting with NSTE-ACS in this population.
- The prevalence of 14.4% underscores the importance of considering non-obstructive causes in NSTE-ACS.
- Further research is recommended to elucidate pathophysiology and optimize management for non-obstructive coronary artery disease (NOCA) in NSTE-ACS.
Related Concept Videos
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Imaging Studies for Cardiovascular System I:Echocardiography
331
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
331
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
513
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
513
Antianginal Drugs: Nitrates and β-Blockers
590
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
590


